Table 1.
Patient Characteristics
Parameters | Values |
---|---|
Age, y | 58.9±13.3 |
Male, n | 119 (67.2) |
BSA, m2 | 1.89±0.28 |
Hispanic, n | 39 (22.0) |
Non‐Hispanic White, n | 84 (47.5) |
Non‐Hispanic Black, n | 39 (22.0) |
Non‐Hispanic Asian, n | 9 (5.1) |
Non‐Hispanic Mix, n | 6 (3.4) |
Nonischemic FMR, n | 116 (65.5) |
Ischemic FMR, n | 61 (34.5) |
LVEF, % | 25.2±7.7 |
LVEDV, mL* | 186.0 (143.5–249.0) |
LVESV, mL* | 135.5 (100.0–193.8) |
E/A ratio* | 2.19 (1.53–2.68) |
E/e′ ratio* | 15.2 (11.5–20.6) |
LAVI, mL/m2* | 47.8 (39.5–58.3) |
TRPG, mm Hg | 34.1±12.2 |
TAPSE, cm* | 1.49 (1.18–1.80) |
TSV, mL* | 45.9 (36.3–57.3) |
LVOT FSV, mL* | 27.6 (21.5–36.1) |
EOA by volumetric method, cm2* | 0.11 (0.06–0.19) |
Rvol by volumetric method, mL* | 16.9 (9.5–24.8) |
RF by volumetric method, % | 36.9±16.8 |
Pulmonary venous flow reversal, n | 39 (22.0) |
MR jet reached LA posterior wall, n | 115 (64.9) |
Wide MR jet or 2 MR jets, n | 119 (67.2) |
EOA by PISA method, cm2* | 0.18 (0.10–0.29) |
Rvol by PISA method, mL* | 24.7 (14.1–38.6) |
RF by PISA method, % | 60.9±41.8 |
Values are number (%), mean±SD, or *median (interquartile range). BSA indicates body surface area; EOA, effective orifice area; FMR, functional mitral regurgitation; FSV, forward stroke volume; LAVI, left atrial volume index; LVEDV, left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end‐systolic volume; LVOT, left ventricular outflow tract; PISA, proximal isovelocity surface area; RF, regurgitant fraction; Rvol, regurgitant volume; TAPSE, tricuspid annular plane systolic excursion; and TRPG, tricuspid regurgitation peak gradient.